Recent Analysts’ Ratings Changes for Guardian Pharmacy Services (GRDN)

Several analysts have recently updated their ratings and price targets for Guardian Pharmacy Services (NYSE: GRDN):

• 9/22/2026 – Guardian Pharmacy Services is now covered by KeyCorp. They set an “overweight” rating and a $52.00 price target on the stock.
• 9/22/2026 – Guardian Pharmacy Services was given a new $52.00 price target by KeyCorp. They now have an “overweight” rating on the stock.
• 9/22/2026 – Guardian Pharmacy Services is now covered by KeyCorp. They set an “overweight” rating and a $52.00 price target on the stock.
• 9/21/2026 – Guardian Pharmacy Services had its price target raised by Truist Financial Corporation from $47.00 to $51.00. They now have a “buy” rating on the stock.
• 9/19/2026 – Guardian Pharmacy Services was downgraded by Wall Street Zen from “buy” to “hold”.
• 8/20/2026 – Guardian Pharmacy Services was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.

Guardian Pharmacy Services, Inc (NYSE: GRDN) is a healthcare services company that provides pharmacy services to residents of long-term care and other institutional healthcare settings. Its customers include assisted living communities, skilled nursing facilities, behavioral health centers and communities serving individuals with developmental disabilities.

The company’s services include prescription dispensing, medication packaging and delivery, medication management, pharmacy consulting and clinical support.